World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
53197
World Ranking
11507
National Ranking
5899

Overview

Prakash Deedwania is affiliated with the United States Department of Veterans Affairs in the United States. Their work primarily centers in the field of medicine, with a significant focus on cardiology and cardiovascular medicine. Their contributions span multiple subfields including endocrinology, diabetes and metabolism, economics and econometrics, surgery, and pulmonary and respiratory medicine.

Their research topics cover a range of cardiovascular and metabolic health areas, notably:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Lipoproteins and Cardiovascular Health
  • Blood Pressure and Hypertension Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes Treatment and Management
  • Pharmaceutical Economics and Policy

Deedwania has published extensively in various medical journals. The venues in which they frequently appear include:

  • The American Journal of Medicine (12 publications)
  • Journal of the American College of Cardiology (9 publications)
  • Circulation (4 publications)
  • Progress in Cardiovascular Diseases (3 publications)
  • American Journal of Cardiovascular Drugs (3 publications)

Notable recent papers authored or co-authored by Prakash Deedwania include:

  • "Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association," 2020, Circulation
  • "Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association," 2021, Circulation
  • "Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association," 2023, Circulation
  • "Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy," 2020, JAMA Cardiology
  • "Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure," 2020, Journal of the American College of Cardiology

Their frequent co-authors reflect a collaborative research network, including:

  • Gregg C. Fonarow
  • Phillip H. Lam
  • Charles Faselis
  • Ali Ahmed
  • Richard M. Allman

Deedwania's work intersects clinical cardiology, public health, and health economics. This interdisciplinary approach underscores their involvement in studies ranging from pharmacological interventions and heart failure management to the broader health system evaluations and policy impacts related to cardiovascular and metabolic diseases.

Best Publications

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina)

    Raymond J. Gibbons;Jonathan Abrams;Kanu Chatterjee;Jennifer Daley

  • Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

    Bertram Pitt;Robert Segal;Felipe A Martinez;Georg Meurers

  • Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association

    Jay S. Skyler;Richard Bergenstal;Robert O. Bonow;John Buse

  • Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

    S N Singh;R D Fletcher;S G Fisher;B N Singh

  • Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

    William E. Boden;Robert A. O'Rourke;Michael H. Crawford;Alvin S. Blaustein

  • Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

    Sander J. Robins;Dorothea Collins;Janet T. Wittes;Vasilios Papademetriou

  • Executive summary: HFSA 2006 comprehensive heart failure practice guideline

    Kirkwood F. Adams;Jo Ann Lindenfeld;J. Malcolm O. Arnold;David W. Baker

  • Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

    Caroline S. Fox;Sherita Hill Golden;Cheryl Anderson;George A. Bray

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure

    Jay Cohn;Morton Hawkins;Herbert Levine;John Naughton

  • Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.

    James Shepherd;Philip Barter;Rafael Carmena;Prakash Deedwania

  • Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT)

    Prakash C. Deedwania;Bramah N. Singh;Kenneth Ellenbogen;Susan Fisher

  • Consensus recommendations for the management of chronic heart failure: Introduction

    Milton Packer;Jay N. Cohn;William T. Abraham;Wilson S. Colucci

  • National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

    Terry A. Jacobson;Kevin C. Maki;Carl E. Orringer;Peter H. Jones

  • Hyperglycemia and Acute Coronary Syndrome A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism

    Prakash Deedwania;Mikhail Kosiborod;Eugene Barrett;Antonio Ceriello

  • Effect of nateglinide on the incidence of diabetes and cardiovascular events

    Rury R. Holman;Steven M. Haffner;Steven M. Haffner;John J. McMurray;M. Angelyn Bethel;M. Angelyn Bethel

  • Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

    John J.P. Kastelein;Wim A. van der Steeg;Ingar Holme;Michael Gaffney

  • HFSA 2006 comprehensive heart failure practice guideline

    Kirkwood F. Adams;Jo Ann Lindenfeld;J. Malcolm O. Arnold;David W. Baker

Frequent Co-Authors

Ali Ahmed
Ali Ahmed Georgetown University
Gregg C. Fonarow
Gregg C. Fonarow University of California, Los Angeles
Wilbert S. Aronow
Wilbert S. Aronow New York Medical College
Richard M. Allman
Richard M. Allman George Washington University
Javed Butler
Javed Butler University of Mississippi
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Rajeev Gupta
Rajeev Gupta Rajasthan University of Health Sciences
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Nanette K. Wenger
Nanette K. Wenger Emory University
Kanu Chatterjee
Kanu Chatterjee University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not ready for the commitment of studying Medicine in the USA, there are affordable online programs that offer practical career pathways. Medical billing and coding is one rapidly growing field; by enrolling in how much is medical billing and coding school, you can assess tuition costs and program options to get started in healthcare administration.

For those who want a clinical role, becoming a nurse is a popular and accessible option. If you’re asking what is the cheapest online college for nursing?, you will find a range of accredited and flexible RN and BSN programs that are budget-friendly. Many registered nurses eventually aim to become nurse practitioners—explore the cheapest fnp programs to continue your education with a strong clinical focus.

Those seeking leadership in academic or advanced clinical settings can consider a Doctor of Nursing Practice (DNP). You can review the cheapest dnp online program to find doctoral-level opportunities that support your career growth without significant financial burden.

Best Scientists Citing Prakash Deedwania

Trending Scientists